Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Affiliations

¹ Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet, Stockholm, 171 76, Sweden. Aikaterini.chatzidionysiou@karolinska.se.
² Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
³ ARBITER, Institute of Rheumatology, Moscow, Russia.
⁴ DANBIO, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark.
⁵ Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
⁶ Cantacuzino Hospital, Bucharest, Romania.
⁷ Charles University, Prague, Czech Republic.
⁸ ROB-FIN Helsinki University Central Hospital, Helsinki, Finland.
⁹ SCQM registry, University Hospital of Geneva, Geneva, Switzerland.
¹⁰ Rheumatic Diseases Portuguese Register, Rheumatology Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
¹¹ University Medical Center, Ljubljana, Slovenia.
¹² Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
¹³ Hospital Clinico Universitet De Santiago, Santiago, Spain.
¹⁴ Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet, Stockholm, 171 76, Sweden.

Published Erratum

Katerina Chatzidionysiou et al. Arthritis Res Ther. 2016.

. 2016 Jun 20;18(1):144.

doi: 10.1186/s13075-016-1048-4.

¹ Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet, Stockholm, 171 76, Sweden. Aikaterini.chatzidionysiou@karolinska.se.
² Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
³ ARBITER, Institute of Rheumatology, Moscow, Russia.
⁴ DANBIO, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark.
⁵ Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
⁶ Cantacuzino Hospital, Bucharest, Romania.
⁷ Charles University, Prague, Czech Republic.
⁸ ROB-FIN Helsinki University Central Hospital, Helsinki, Finland.
⁹ SCQM registry, University Hospital of Geneva, Geneva, Switzerland.
¹⁰ Rheumatic Diseases Portuguese Register, Rheumatology Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
¹¹ University Medical Center, Ljubljana, Slovenia.
¹² Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
¹³ Hospital Clinico Universitet De Santiago, Santiago, Spain.
¹⁴ Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet, Stockholm, 171 76, Sweden.

No abstract available

Erratum for

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.
Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Ancuta I, Pavelka K, Nordström DC, Gabay C, Canhão H, Tomsic M, van Riel PL, Gomez-Reino J, Kvien TK, van Vollenhoven RF; Rheumatic Diseases Portuguese Register. Chatzidionysiou K, et al. Arthritis Res Ther. 2016 Feb 16;18:50. doi: 10.1186/s13075-016-0951-z. Arthritis Res Ther. 2016. PMID: 26883119 Free PMC article.

1. Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Ancuta I, Pavelka K, Nordström DC, Gabay C, Canhão H, Tomsic M, van Riel PLCM, Gomez-Reino J, Kvien TK, van Vollenhoven RF. Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. Arthritis Res Ther. 2016;18:50. doi: 10.1186/s13075-016-0951-z. - DOI - PMC - PubMed